Erlotinib is also being evaluated in combination with capecitabine in patients who failed first-line therapy with gemcitabine.
厄罗替尼布联合卡培他滨同样用于一线药物吉西他滨治疗失败的患者。
Until recently, if an infection proved resistant to first-line therapy, an alternative or combination was generally available.
不久前,如果一种感染对一线的药物疗法表现出耐药性,通常可以选择一种替代药物或实施联合用药。
Caspofungin first-line therapy was effective and well tolerated in allogeneic hematopoietic SCT patients with mycologically documented IA.
卡泊芬净一线治疗异基因造血干细胞移植患者侵袭性真菌病是有效且可耐受的。
应用推荐